EquityFlow › Companies › RocketVax

RocketVax

Biotech · Basel, CH

Biotech developing a second-generation Covid-19 vaccine.

Funding history

Date	Round	Amount
Aug 2021	Series A Basel biotech RocketVax raised a CHF 7.2M Series A to fund pre-clinical development of its Covid-19 vaccine.	$6.6M

Investors

InnoSuisse

Similar companies in Biotech

Imperagen Haga Bioscience Pixelgen Technologies Gallant Chai Discovery SNIPR Biome Cellbox Labs Scope Biosciences GenLumina Actithera NUCLIDIUM Anocca

Explore funding flow on EquityFlow →